ATNM | Actinium Pharmaceuticals Inc 8.54 -0.26 (-3.14%)
Category: Consumer goods
Quick infos Trade prices Volume: Market Cap: Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends:
Earnings History Date EPS / Forecast Revenue / Forecast November 24, 2020 -0.36 / -0.3575- / -August 31, 2020 -0.41 / -0.37- / 6.9MAugust 17, 2020 - / -0.02- / 6.9MMay 11, 2020 - / -0.04- / 6.62MMarch 30, 2020 - / -0.04- / -view more
Historical Data Date Price Open High Low Vol Change ER Jan 12, 2021 8.6000 8.2800 8.7499
8.1100
527.39K 3.86% Jan 11, 2021 8.2800 8.2200 8.5800
7.9600
520.59K 0.49% Jan 8, 2021 8.2400 8.4200 8.5511
8.1200
365.60K -3.96% Jan 7, 2021 8.5800 8.0300 8.5900
8.0200
688.99K 6.98% Jan 6, 2021 8.0200 8.5500 8.5800
7.9500
654.99K -6.42% Jan 5, 2021 8.5700 8.0500 8.6000
7.8900
632.25K 9.03% Jan 4, 2021 7.8600 7.9900 8.3560
7.7800
857.14K 0.77% Dec 31, 2020 7.8000 8.3000 8.3000
7.7038
1.43M -4.41% Dec 30, 2020 8.1600 8.5200 8.7950
8.1400
1.23M 0.99% Dec 29, 2020 8.0800 8.6700 8.7900
7.8000
3.71M -24.63% view more
News
Actinium Pharmaceuticals Successfully Completes First Dosing Cohort in the Phase 1 Study of Actimab-A and Venetoclax Combination Therapy in Relapsed/Refractory AML Patients finance.yahoo.com Sep 23, 2020 7:00 am
Actinium Pharmaceuticals, Inc. to Present at the 22nd Annual H.C. Wainwright Global Investor Conference finance.yahoo.com Sep 10, 2020 7:00 am
Actinium Pharmaceuticals, Inc. Announces Proposed Public Offering finance.yahoo.com Sep 4, 2020 4:01 pm
Benzinga's Top Upgrades, Downgrades For June 4, 2020 finance.yahoo.com Sep 4, 2020 9:42 am
Actinium Pharmaceuticals to Present New Clinical Findings from SIERRA Trial Supporting the Iomab-ACT Program for Targeted Lymphodepletion for CAR-T and Adoptive Cell Therapies at ASH 2019 finance.yahoo.com Sep 4, 2020 9:00 am
Is Actinium Pharmaceuticals (ATNM) Outperforming Other Medical Stocks This Year? finance.yahoo.com Aug 28, 2020 11:30 am Actinium Pharmaceuticals to reverse split shares 1:30 seekingalpha.com Aug 11, 2020 2:56 am Actinium Pharmaceuticals files for $500M mixed shelf seekingalpha.com Aug 8, 2020 4:06 am
Actinium Pharmaceuticals, Inc. to Present at the 22nd Annual BIO CEO & Investor Conference finance.yahoo.com Sep 4, 2020 8:03 am
Actinium's Late Breaking Oral Presentation at 2019 TCT Meetings Reports New Data on Donor Chimerism Indicating Deep Engraftment in All Iomab-B Treated Patients in the Pivotal Phase 3 SIERRA Trial finance.yahoo.com Sep 4, 2020 8:00 am
Actinium Pharmaceuticals Announces Iomab-ACT Program Gene Therapy Collaboration with UC Davis in Ongoing Clinical Trial for Patients with HIV-Related Lymphoma finance.yahoo.com Sep 4, 2020 7:03 am
Actinium Pharmaceuticals Announces Phase 3 SIERRA Trial Dosimetry Results Support Low Dose Iomab-B for Targeted Lymphodepletion Prior to Adoptive Cell Therapy finance.yahoo.com Sep 4, 2020 6:00 am
LD Micro: 360 Companies Set to Present this Week finance.yahoo.com Aug 31, 2020 6:05 pm
Is a Surprise Coming for Actinium Pharmaceuticals (ATNM) This Earnings Season? finance.yahoo.com Aug 26, 2020 8:48 am
Actinium Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Highlights finance.yahoo.com Aug 14, 2020 5:00 pm
Actinium Pharmaceuticals, Inc. Announces Proposed Public Offering finance.yahoo.com Aug 14, 2020 4:01 pm
Actinium Pharmaceuticals (ATNM) is a Great Momentum Stock: Should You Buy? finance.yahoo.com Aug 14, 2020 12:00 pm
Actinium Pharmaceuticals to Present at the Oppenheimer & Co. 29th Annual Healthcare Conference finance.yahoo.com Aug 14, 2020 8:00 am
Actinium Highlights Actimab-A and Venetoclax Synergies Observed in New Studies Presented at AACR finance.yahoo.com Aug 14, 2020 8:00 am
Is Actinium Pharmaceuticals (ATNM) Stock Outpacing Its Medical Peers This Year? finance.yahoo.com Aug 12, 2020 11:30 am Talk about Actinium Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.